Overview
Sclerosing cholangitis is a rare condition characterized by progressive fibrosis and stricturing of the bile ducts, often leading to biliary obstruction and liver disease. It can occur as part of a broader syndrome involving ectodermal and hepatic manifestations, such as in the ILVASC syndrome linked to CLDN1 mutations 1.Diagnosis
Genetic Testing: Identification of CLDN1 variants, particularly p.Arg81His, in patients with a phenotype including ichthyosis, leukocyte vacuoles, alopecia, and liver involvement 1.
Imaging Studies: Use of CT, ultrasound, and percutaneous transhepatic cholangiography to visualize bile duct abnormalities and ectopic gallbladder anomalies 2.
Liver Function Tests: Elevated liver enzymes indicative of cholestasis and potential liver dysfunction.
Endoscopic Retrograde Cholangiopancreatography (ERCP): Diagnostic and therapeutic intervention for visualizing and managing biliary strictures 1.Management
Percutaneous Drainage: For biliary obstruction, percutaneous cholecystostomy or transhepatic biliary drainage can be performed 2.
Endoscopic Management: ERCP for both diagnostic evaluation and interventions like stent placement to relieve biliary obstruction 1.
Liver Transplantation: Considered in advanced cases with end-stage liver disease 1.
Supportive Care: Management of symptoms and complications, including nutritional support and dermatological care for ectodermal manifestations 1.Special Populations
Genetic Considerations: Increased vigilance for CLDN1 mutations in North African Jewish populations 1.
Pediatrics: Early recognition and intervention crucial due to potential for severe liver involvement from early childhood 1.Key Recommendations
Genetic Screening for CLDN1 Variants in patients with clinical features of ILVASC syndrome, particularly in North African Jewish ancestry (Evidence: Moderate 1).
Utilize Imaging Techniques including CT, ultrasound, and percutaneous transhepatic cholangiography for accurate diagnosis and management planning (Evidence: Moderate 2).
Consider Percutaneous Drainage as a first-line intervention for biliary obstruction in sclerosing cholangitis (Evidence: Weak 2).References
1 Eskin-Schwartz M, Dolgin V, Didkovsky E, Aminov I, Pikovsky A, Hadar N et al.. CLDN1 Arg81His founder variant causes ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis (ILVASC) syndrome in Moroccan Jews. Clinical genetics 2024. link
2 Feldman L, Venta L. Percutaneous cholecystostomy of an ectopic gallbladder. Gastrointestinal radiology 1988. link